Stock Track | CareDx Plunges 6.26% Pre-Market as Jefferies Slashes Price Target

Stock Track
Aug 07

CareDx (CDNA) shares tumbled 6.26% in pre-market trading on Thursday, following a significant price target cut by Jefferies. The investment bank reduced its target price for the company from $25 to $21, signaling decreased confidence in the stock's near-term potential.

This downward revision in price target appears to have sparked a sell-off among investors, leading to the sharp decline in CareDx's stock price. The company, which specializes in transplant diagnostics, may face challenges that prompted Jefferies to reassess its valuation.

Investors and market participants will likely be closely watching for any additional analyst comments or company updates that could provide more insight into the factors behind this price target reduction and the subsequent stock movement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10